Wei Lu
35Patents
13h-index
32Co-inventors
77Inventor score
Filing activity: Mar 5, 2013 → Nov 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9187474B2 | Raf inhibitor compounds | Chemistry; Metallurgy | 51 | Active |
| US9334267B2 | RAF inhibitor compounds | Chemistry; Metallurgy | 51 | Active |
| US9771349B2 | Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 26 | Active |
| US9624216B2 | Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9624175B2 | Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 25 | Active |
| US10005734B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 25 | Active |
| US9815817B2 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 24 | Active |
| US9834539B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 24 | Active |
| US10253015B2 | Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 19 | Active |
| US10280150B2 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US10266495B2 | Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US10414752B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 16 | Active |
| US10550098B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 15 | Active |
| US10294206B2 | Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10407419B2 | Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10550099B2 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10889567B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 4 | Active |
| US10577329B2 | Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10399951B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 4 | Active |
| US10457655B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US11498913B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 3 | Active |
| US10472342B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US11497743B2 | Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation | Chemistry; Metallurgy | 3 | Active |
| US10450286B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US10807976B2 | Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.